AXSM
157.14-4.65 -2.87%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- AXSM
- Exchange
- NGM
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $8.27B
- Employees
- 1,346
- Currency
- USD
- Website
- https://www.axsome.com
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptake…
Latest coverage
- 2 Under-the-Radar Stocks to Buy and Hold
October 16, 2026
Related Other stocks
UnitedHealth Group IncorporatedUNH
J.B. Hunt Transport Services, Inc.JBHT
Zillow Group, Inc.ZG
Opendoor Technologies Inc.OPEN